Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma

Behzatoglu K., YÖRÜKOĞLU K., Demir H., Bal N.

EUROPEAN UROLOGY FOCUS, cilt.4, sa.3, ss.399-404, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 4 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.euf.2016.06.007
  • Dergi Adı: EUROPEAN UROLOGY FOCUS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.399-404
  • Anahtar Kelimeler: HER2, Immunohistochemistry, Urothelial carcinoma, Micropapillary, Variants, Targeted therapy
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background: Human epidermal growth factor receptor 2 (HER2) protein overexpression or gene amplification has been shown in urothelial bladder cancer. This could be helpful when using targeted anti-HER2 therapy on these tumors.